Cytokine profile in cases with premature elevation of progesterone serum concentrations during ovarian stimulation.
The aim of this study was to investigate the concentrations of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), leptin, tumor necrosis factor-alpha, interleukin (IL)-1beta and IL-6, in cycles with a premature rise of serum progesterone. 25 intracytoplasmic sperm injection (ICSI) cycles with (Group 1) and 25 ICSI cycles without a premature progesterone elevation (Group 2) were included. The cut-off value of serum progesterone on the day of human chorionic gonadotropin (hCG) administration was 0.9 ng/ml. The indication for ICSI was male factor infertility exclusively. On the day of hCG injection, serum IL-6, VEGF and bFGF were significantly higher in Group 1 (7.7+/-24.5 pg/ml, 290.2+/-161.4 pg/ml and 15.7+/-8.2 ng/ml respectively) than in Group 2 (1.7+/-0.7 pg/ml, 175.2+/-92.1 pg/ml, and 9+/-1.6 ng/ml respectively). On the day of follicular puncture, serum cytokine concentrations were similar in the two groups. IL-6 intrafollicular concentrations were higher in Group 1 (14.7+/-20.7 pg/ml) than in Group 2 (9+/-9.3 pg/ml, p=0.031). There were no differences regarding the ICSI outcome. Patients with serum progesterone above 0.9 ng/ml, have elevated serum concentrations of IL-6, VEGF, and bFGF, as well as elevated intrafollicular concentrations of IL-6. The outcome of ICSI cycles is not associated with premature elevation of progesterone when the cut-off value is set at 0.9 ng/ml.
Nikolettos
N
N
School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. basima@med.duth.gr
Asimakopoulos
B
B
Köster
F
F
Schöpper
B
B
Schulz
Ch
Ch
Caglar
G S
GS
Efthimiadou
A
A
Pagonopoulou
O
O
Diedrich
K
K
Al-Hasani
S
S
D000328:Adult; D000704:Analysis of Variance; D016022:Case-Control Studies; D016207:Cytokines / Q000378:metabolism*; D004958:Estradiol / Q000097:blood; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D015571:Follicular Fluid / Q000378:metabolism; D006801:Humans; D053583:Interleukin-1beta / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism*; D020738:Leptin / Q000097:blood; D008597:Menstrual Cycle / Q000378:metabolism; D010062:Ovulation Induction; D011374:Progesterone / Q000097:blood*; D012016:Reference Values; D020554:Sperm Injections, Intracytoplasmic; D013739:Testosterone / Q000097:blood; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D016207:Cytokines; D053583:Interleukin-1beta; D015850:Interleukin-6; D020738:Leptin; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D016222:Fibroblast Growth Factor 2; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol